Yi-Ying Wu

760 total citations
8 papers, 556 citations indexed

About

Yi-Ying Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi-Ying Wu has authored 8 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Yi-Ying Wu's work include Cancer-related molecular mechanisms research (3 papers), Barrier Structure and Function Studies (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yi-Ying Wu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Barrier Structure and Function Studies (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Yi-Ying Wu collaborates with scholars based in Taiwan, United States and India. Yi-Ying Wu's co-authors include Tse‐Ming Hong, Pan‐Chyr Yang, Shuenn-Chen Yang, Szu‐Hua Pan, Yuh-Ling Chen, Ting-Fang Che, Jin‐Yuan Shih, Wing‐Kai Chan, Ang Yuan and Ming-Heng Wu and has published in prestigious journals such as Nature Communications, American Journal of Respiratory and Critical Care Medicine and Oncogene.

In The Last Decade

Yi-Ying Wu

8 papers receiving 549 citations

Peers

Countries citing papers authored by Yi-Ying Wu

Since Specialization

Citations

This map shows the geographic impact of Yi-Ying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Ying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Ying Wu more than expected).

Fields of papers citing papers by Yi-Ying Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Ying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Ying Wu. The network helps show where Yi-Ying Wu may publish in the future.

Co-authorship network of co-authors of Yi-Ying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Ying Wu. A scholar is included among the top collaborators of Yi-Ying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Ying Wu. Yi-Ying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression 2020 ·Theranostics ·(unknown), Yi-Ying Wu, (unknown), Yao‐Tsung Tsai, Hsuan‐Yu Chen, Yuh-Ling Chen, Tse‐Ming Hong	21
2	MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer 2019 ·Oncogene ·(unknown), (unknown), (unknown), Yi-Ying Wu, Yao‐Tsung Tsai, (unknown), Keng‐Fu Hsu, Yuh-Ling Chen, Tse‐Ming Hong	27
3	The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens 2019 ·Journal of Experimental & Clinical Cancer Research ·Yi-Ying Wu, (unknown), (unknown), Kuo‐Yen Huang, Shuenn-Chen Yang, (unknown), Chao-Jung Tsao, Keng‐Fu Hsu, Yuh-Ling Chen, Tse‐Ming Hong	37
4	Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis 2016 ·Nature Communications ·Ching-Wen Lin, (unknown), Shu‐Ping Wang, Yih‐Leong Chang, Yi-Ying Wu, Hsuan‐Yu Chen, Tzu-Hung Hsiao, Wei‐Yun Lai, Hsuan‐Hsuan Lu, Ya-Hsuan Chang, Shuenn-Chen Yang, Ming‐Wei Lin, Chi‐Yuan Chen, Tse‐Ming Hong, Pan‐Chyr Yang	76
5	Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma 2016 ·Oncotarget ·Jan‐Gowth Chang, (unknown), Yi-Ying Wu, Ting-Fang Che, (unknown), Kun-Tu Yeh, Grace S. Shieh, Pan‐Chyr Yang	11
6	Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC 2015 ·Oncotarget ·Ting-Fang Che, Ching-Wen Lin, Yi-Ying Wu, Yu‐Ju Chen, Chia‐Li Han, Yih‐Leong Chang, Chen‐Tu Wu, Tzu-Hung Hsiao, Tse‐Ming Hong, Pan‐Chyr Yang	75
7	Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma 2008 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Szu‐Hua Pan, Shuenn-Chen Yang, Sung‐Liang Yu, Ting-Fang Che, Chung‐Wu Lin, (unknown), Gee‐Chen Chang, (unknown), Yi-Ying Wu, Yung‐Chie Lee, Tse‐Ming Hong, Pan‐Chyr Yang	146
8	Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer 2007 ·Clinical Cancer Research ·Tse‐Ming Hong, Yuh-Ling Chen, Yi-Ying Wu, Ang Yuan, (unknown), (unknown), Ming-Heng Wu, Shuenn-Chen Yang, Szu‐Hua Pan, Jin‐Yuan Shih, Wing‐Kai Chan, Pan‐Chyr Yang	163

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact